Skip to main content
Signal8

Quantum Biopharma Ltd. (QNTM)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Quantum BioPharma Ltd. logo

Quantum BioPharma Ltd.

NASDAQ:QNTMHealthcare
AH+1.79%$2.27
Close$2.23+5.94%
Mkt Cap$18.03M
Float–
O/S8.09M
VOL76K sh
$ Vol$165K
RVOL0.81×
Inst Own7.6%
Dilution
Quantum BioPharma Ltd. logoNASDAQ:QNTMAH$2.27+1.79%
Historical Data
DateOpenHighLowCloseVolume
Nov 9, 20262.132.312.062.2376,185
Nov 6, 20262.052.172.042.1043,625
Nov 5, 20262.202.202.062.1180,582
Nov 4, 20262.212.252.172.2145,578
Nov 3, 20262.272.342.212.2145,292
Nov 2, 20262.412.442.202.2657,377
Oct 30, 20262.452.472.292.3876,834
Oct 29, 20262.432.502.352.4452,674
Oct 28, 20262.422.422.352.37103,350
Oct 27, 20262.212.402.172.3286,828
Oct 26, 20262.202.242.092.21176,513
Oct 23, 20262.262.372.242.2442,708
Oct 22, 20262.372.432.252.27150,419
Oct 21, 20262.452.482.372.4090,607
Oct 20, 20262.422.552.412.4351,736
Oct 19, 20262.492.552.402.4163,599
Oct 16, 20262.682.752.462.47190,810
Oct 15, 20262.652.742.602.71107,517
Oct 14, 20262.852.892.662.66180,882
Oct 13, 20262.832.972.802.8984,863
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
7.6%
Institutional
(27)
0.0%
Insiderⓘ
(0)
4.6%
5%+ Owners
(1)
87.7%
Unattributed (incl. retail)ⓘ
Institutional7.6%
5%+ Beneficial4.6%
Unattributed (incl. retail)87.7%
Top Shareholders
NameShares%
AdvisorShares Investments LLC logo
AdvisorShares Investments LLC
400.4K5.0%
AdvisorShares Trust logo
AdvisorShares Trust
· also on 13F· may incl. warrants· filed Oct 2026
400.4K5.0%
Malone Wealth Ventures LLC logo
Malone Wealth Ventures LLC
· may incl. warrants· filed Feb 2026
375.8K4.6%
JANE STREET GROUP, LLC logo
JANE STREET GROUP, LLC
48.4K0.6%
Platform Technology Partners logo
Platform Technology Partners
41.1K0.5%
UBS Group AG logo
UBS Group AG
33.4K0.4%
Steward Partners Investment Advisory, LLC logo
Steward Partners Investment Advisory, LLC
27.9K0.3%
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
15.9K0.2%
Marex Group Ltd logo
Marex Group Ltd
13.4K0.2%
Mariner, LLC logo
Mariner, LLC
10.0K0.1%
Sources: 13F, 13D/13GO/S: 8.1M · checked 9 Nov 2026 · market-data provider
Insiders & Institutional Holders
About

Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates.

The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.

Its operations are divided into two main divisions: its core biopharmaceutical activities and strategic investment holdings. A flagship asset is Lucid-MS, a novel, proprietary chemical entity currently in Phase 2 clinical trials. Preclinical data indicates its potential to prevent and reverse the degradation of myelin, a key process underlying multiple sclerosis. Furthermore, Quantum BioPharma is developing a therapeutic solution for alcohol addiction, intended for application in hospital and clinical environments.

The company's strategic investments portfolio includes various loans collateralized by residential real estate. Previously known as FSD Pharma Inc., the company adopted its current name, Quantum BioPharma Ltd., in August 2024.

Key Metrics
Market Cap$18.03M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership7.64%

based on 8.09M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryCACA
IPO DateJun 8, 2018
Shares Outstanding8.09M
Authorized Shares
Float–
52-Week Range
$2.04$12.42
$2.23(2nd percentile)
Volume
Average Daily Volume93.60K
76.18K today vs 93.60K avg(-19%)

30d Avg

93.60K

60d Avg

151.81K

90d Avg

174.75K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...